Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,240 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07435428RecruitingPhase 3
Study of a new treatment for moderate to severe frown lines between eyebrows
This trial tests a new medication's effectiveness and safety over time in adults with moderate to severe frown lines between the eyebrows. It aims to see if the treatment can reduce these lines and improve satisfaction with appearance.
Los Angeles, CaliforniaAges 18–80 - NCT06630377Recruiting
Testing GOS for lowering high uric acid
This study tests whether a prebiotic called GOS (a type of dietary fiber) can help lower high uric acid levels naturally, without medication. If you have high uric acid and want a non-drug option, this trial may be a good fit.
Guangzhou, GuangdongAges 18–80 - NCT07437222Recruiting
Ginger capsules for inflammation in overweight adults
This study tests whether taking ginger capsules can help reduce inflammation, oxidative stress, and improve blood vessel function in people who are overweight or obese but otherwise healthy. You would take ginger capsules daily for several weeks and have your blood and blood vessel health checked.
Murcia, MurciaAges 23–65 - NCT06382649RecruitingPhase 2
Rivastigmine for drug-induced confusion
This study tests whether the drug rivastigmine can help people who are very agitated and confused due to certain drug side effects. If it works, it could calm them down and improve their confusion.
St Louis, MissouriAges 10 years+ - NCT06995287RecruitingPhase 3
Botulinum toxin injection for severe period pain
This trial tests whether injecting botulinum toxin into the uterine muscle during a hysteroscopy can reduce severe period pain or chronic pelvic pain that hasn't improved with standard treatments. It may be an option for women who have tried hormonal therapy and pain relievers without success.
Aix-en-ProvenceAges 18 years+ - NCT05970783RecruitingPhase 3
Jincaopian tablets for ongoing pelvic pain after pelvic infection
This trial tests whether Jincaopian tablets can reduce long-lasting pelvic pain that happened after pelvic inflammatory disease. You may be able to join if your pain is still moderate to severe and other causes of pelvic pain have been ruled out.
Beijing, Beijing MunicipalityAges 18–50 - NCT07108283RecruitingPhase 2
Zasocitinib for adults with nonsegmental vitiligo
This trial tests an oral medication called zasocitinib to see if it can help repigment skin in adults with nonsegmental vitiligo. It may be an option for people whose vitiligo covers a moderate amount of their body and who have not had certain recent treatments.
Bryant, ArkansasAges 18–75 - NCT07514416RecruitingPhase 1
Safety study of LCFA-01 drug in healthy women
This study tests a new drug called LCFA-01 to make sure it's safe and works as expected in healthy women. The drug is being developed to treat bacterial vaginosis, a common vaginal infection.
Brisbane, QueenslandAges 18–40 - NCT06591091RecruitingPhase 2
Clemastine for Depression in Older Adults
This study tests if adding clemastine (an allergy medication) to standard antidepressants can improve brain health and boost treatment response in adults over 60 with depression.
Chicago, IllinoisAges 60 years+ - NCT07310485Enrolling by invitation
Phytoestrogens for premenstrual syndrome in women nearing menopause
This trial tests whether plant-based compounds (phytoestrogens) can help reduce premenstrual syndrome symptoms in women aged 40–55. It also looks at how these supplements affect gene activity.
Amman, Amman GovernorateAges 40–55 - NCT07733089RecruitingPhase 1
Testing a new psoriasis drug for safety and effect
This trial tests a new study drug (ZP9830) to see if it is safe and works well for people with plaque psoriasis. You would receive the treatment for 8 weeks, and the study will check how your skin responds.
Leiden, South HollandAges 18–60 - NCT05978050RecruitingPhase 3
Nimotuzumab plus paclitaxel for recurring stomach cancer
This Phase 3 trial tests whether adding nimotuzumab (an anti-EGFR antibody) to paclitaxel can improve outcomes for people with stomach or stomach-junction cancer that has returned and spread. It targets tumors with high EGFR (“EGFR high” on a pathology test) to see if this combination works better than standard treatment.
Guangzhou, GuangdongAges 18–75 - NCT06569212RecruitingPhase 4
Beta-blocker to reduce heart damage after brain bleed
This trial tests whether a common beta-blocker (metoprolol) can protect the heart from injury and reduce inflammation after a bleed in the brain (subarachnoid hemorrhage). It may help patients recover better after this type of stroke.
Portland, MaineAges 18 years+ - NCT07734649RecruitingPhase 1/Phase 2
RSV and HMPV vaccine study for adults 60 and older
This study tests a new vaccine that targets two respiratory viruses, RSV and HMPV, to see if it's safe and effective in adults 60 years and older. It may help prevent serious lung infections caused by these viruses.
Gadsden, AlabamaAges 60 years+ - NCT06990711RecruitingPhase 1
Siltuximab for antibody-mediated rejection after lung transplant
This trial tests a drug called siltuximab to see if it can help treat a type of lung rejection called antibody-mediated rejection (AMR) in people who have had a lung transplant. You may be eligible if you are currently hospitalized for AMR and are already planning to receive standard treatments.
St Louis, MissouriAges 18 years+ - NCT06993155RecruitingPhase 2
Leflutrozole for low testosterone and low sperm count
This trial tests a new drug called Leflutrozole to see if it can improve testicular function in men with low testosterone and low sperm count. The goal is to help increase natural hormone levels and sperm production.
North Hollywood, CaliforniaAges 18–49 - NCT07314411Recruiting
Carotenoids for Eye Health in Healthy Adults
This study tests if taking a carotenoid supplement (MacuHealth) can improve or protect retinal health in healthy adults. You might join if you have normal vision and no major eye or health problems.
Forest Grove, OregonAges 18–75 - NCT07281885Recruiting
Aromatherapy for nausea after joint replacement
This study tests whether aromatherapy with essential oils can help reduce nausea and vomiting after total joint replacement surgery. Participants will receive a simple aromatherapy treatment alongside their regular care.
Wong Tai Sin, Hong KongAges 18 years+ - NCT06529055Enrolling by invitation
Caffeine and nicotine pouch effects on exercise and brain function
This trial tests how caffeine and nicotine pouches affect your body during exercise, including heart function, thinking, and behavior. It looks at short bursts of high-intensity activity in healthy men who already exercise regularly.
Hattiesburg, MississippiAges 21–40 - NCT06002477RecruitingEarly Phase 1
Attention study in sickle cell disease
This trial tests a medication to see if it can improve attention in people with sickle cell disease. It may help with thinking and focus.
Nashville, TennesseeAges 55 years+ - NCT07495813RecruitingPhase 1
Study of RO7763505 in healthy people and stable heart disease
This study tests an experimental drug (RO7763505) in healthy people and people with stable heart disease. It aims to see how safe the drug is and how it works in the body.
GroningenAges 18–75 - NCT06980636RecruitingPhase 4
Shengmai liquid for long covid fatigue trial
This trial tests if a traditional Chinese medicine, Shengmai Liquid, can help reduce fatigue in people with long COVID. It is for adults aged 18 to 75 who feel tired for a long time after a COVID infection.
Beijing, ChinaAges 18–75 - NCT06004882Recruiting
Nerve stimulation vs. steroid injection for chronic knee pain
This study compares two treatments for long-term knee pain: a nerve stimulation device placed near the knee versus a steroid shot into the joint. The goal is to see which works better for pain relief.
Houston, TexasAges 18 years+ - NCT06302491RecruitingPhase 2
Testing AND017 for beta-thalassemia
This trial tests an oral medication called AND017 for people with beta-thalassemia. It aims to see if the drug can safely help reduce the need for blood transfusions or improve hemoglobin levels.
Guangzhou, GuangdongAges 18–65
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,240 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.